antipsychotics were the sixth best selling class of medications globally in , according to ims health they raked in a cool billion , an increase of from thank god we are doing a better job of overrecognizing , er , appropriately treating bipolar disorder antidepressants were , at billion , down nearly seven percent this does not appear to be due to declining prescriptions blame generics , not decreased prescriptions for the lower numbers with cymbalta , lilly has shown that new antidepressants do n't have to be anything special , so it would behoove other companies to release other run of the mill antidepressants , attach a comical , er , highly educational marketing campaign such as depression hurts , then watch the money roll in just some free advice how about the top drugs ? three of them were antipsychotics no , i'm not kidding most surprisingly , zyprexa had the best figures worldwide , which was interesting given the flat u s sales in seroquel outsold zyprexa in the u s , but zyprexa had a better run globally who knows what tricks are being used to sell zyprexa internationally ? never mind , it 's not like lilly would do anything sly to market zyprexa the new era of antipsychotics for everything appears to be in full swing